Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Erik Baptist

This anti-abortion leader is building on ‘the ultimate victory from the supreme court’

Erik Baptist, with Alliance Defending Freedom, has his sights set on mifepristone after the fall of Roe v Wade

The Guardian - US

Dual court rulings throw confusion into abortion drug debate - Roll Call

Two federal judges issued dueling opinions Friday over the FDA's approval of an abortion drug more than 20 years ago.

Roll Call

Judge signals he could rule to halt sales of common abortion pill

During a four-hour hearing last week that could eliminate nationwide access to a common and widely used abortion pill, federal Judge Matthew Kacsmaryk, of the Northern District of Texas, signaled his conservative Christian beliefs early and often.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Abortion pill ruling looms over FDA's drug approval process

"This type of activity would fundamentally de-stabilize the FDA regulatory system," a legal expert said.

Axios

Judge weighs FDA approval of abortion drug

WASHINGTON — A federal district judge heard oral arguments Wednesday in a controversial case that could decide the fate of the Food and Drug Administration’s approval of the abortion drug mifepristone — a decision that would have broad ramifications nationwide.

Tribune News Service

Judge weighs FDA approval of abortion drug - Roll Call

The case examines whether the FDA erred in its approval of a drug commonly used for both abortions and miscarriage management.

Roll Call

Federal judge hears challenge to FDA approval of abortion drug

U.S. District Judge Matthew Kacsmaryk said he would rule “as soon as possible” on the request for a preliminary injunction that would move mifepristone, a common abortion-inducing drug, off the market.

The Texas Tribune

Read news from The Economist, FT, and more,
with one subscription

FDA adds a major new twist to the abortion pill fight

Abortion rights advocates say that if the FDA withdraws its mifepristone approval, it would essentially result in a national ban.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

the Food and Drug Administration

146 stories

Alliance Defending Freedom

37 stories

EMTALA

37 stories

Alliance for Hippocratic Medicine

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.